startups

red and purple piggy banks

Biotech

Syncona cites 'challenging' market for switching investment plan

Life sciences firm Syncona has blamed “particularly challenging” market conditions for shifting its strategy away from early-stage biotechs.

James Waldron Jun 20, 2025 6:00am

Fierce Fundraising Tracker image 2025

Fierce Biotech Fundraising Tracker: Antares, Mosanna & more

Jun 18, 2025 9:00am

dynamic arrows moving up

US biotechs must adapt as global competition rises: Antares CEO

Jun 17, 2025 8:15am

Astellas

Astellas offers lab space to help Japanese biotechs 'go global'

Jun 13, 2025 4:41am

oncology cancer test mammogram mammography breast cancer

FDA clears Clairity's 5-year breast cancer risk prediction tool

Jun 5, 2025 1:00pm

Nominations now open for Fierce Biotech's 2025 Fierce 15

May 20, 2025 7:30am